Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
2024 · Frontiers in Pharmacology · 2 citations
https://doi.org/10.3389/fphar.2024.1453595
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
433
Citations
12
h-index
13
i10-index
Fei Yuan is an academic researcher from Taiyuan Normal University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Hippo pathway signaling and YAP/TAZ & Traditional and Medicinal Uses of Annonaceae. The author has an h-index of 12, co-authored 26 publications.
ORCID: 0000-0001-6230-9634https://doi.org/10.3389/fphar.2024.1453595
https://doi.org/10.1186/s13019-025-03676-4
Click to start Chat